IL10 and colitis: found that in DSS-induced colitis, FMT upregulates the aryl hydrocarbon receptor, IL-10, and transforming growth factor beta (TGF-β) expression in the mouse colon, providing favorable therapeutic effect in limiting DSS-induced colitis (127).